Evidence map›Paper›PMID 37964078›Full record

ArticleNPJ precision oncology2023

Hyperspectral imaging benchmark based on machine learning for intraoperative brain tumour detection.

Raquel Leon, Himar Fabelo, Samuel Ortega, Ines A Cruz-Guerrero, Daniel Ulises Campos-Delgado, Adam Szolna, Juan F Piñeiro, Carlos Espino, Aruma J O'Shanahan, Maria Hernandez and 7 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in NPJ precision oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07036783 (Multimodal Data Collection for the Development and Validation of the STRATUM Tool to Assist Surgery in Patients Affected by Brain Tumours), which is not on this map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07036783 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Multimodal Data Collection for the Development and Validation of the STRATUM Tool to Assist Surgery in Patients Affected by Brain Tumours: Observational Study

Typeobservational_patient_registrySponsorFundación Canaria Instituto de Investigación Sanitaria de CanariasRan2025 to 2027Enrolled320ConditionsBrain (Nervous System) Cancers, Brain Tumor, Primary
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Multimodal HSI-MRI system for tumor delineation in neurosurgical guidance.International journal of computer assisted radiology and surgery · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Observational
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 4 countries.

Raquel Leon *Research Institute for Applied Microelectronics, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain. slmartin@iuma.ulpgc.es.ORCID http://orcid.org/0000-0002-4287-3200
Himar Fabelo *Research Institute for Applied Microelectronics, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain. hfabelo@iuma.ulpgc.es.ORCID http://orcid.org/0000-0002-9794-490X
Samuel OrtegaResearch Institute for Applied Microelectronics, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
Ines A Cruz-GuerreroFacultad de Ciencias, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México.ORCID http://orcid.org/0000-0001-8034-8530
Daniel Ulises Campos-DelgadoFacultad de Ciencias, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México.ORCID http://orcid.org/0000-0002-1555-0131
Adam SzolnaDepartment of Neurosurgery, University Hospital Doctor Negrin of Gran Canaria, Las Palmas de Gran Canaria, Spain.
Juan F PiñeiroInstituto de Investigación en Comunicación Óptica, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México.
Carlos EspinoDepartment of Neurosurgery, University Hospital Doctor Negrin of Gran Canaria, Las Palmas de Gran Canaria, Spain.
Aruma J O'ShanahanDepartment of Neurosurgery, University Hospital Doctor Negrin of Gran Canaria, Las Palmas de Gran Canaria, Spain.
Maria HernandezDepartment of Neurosurgery, University Hospital Doctor Negrin of Gran Canaria, Las Palmas de Gran Canaria, Spain.
David CarreraDepartment of Neurosurgery, University Hospital Doctor Negrin of Gran Canaria, Las Palmas de Gran Canaria, Spain.
Sara BisshoppDepartment of Neurosurgery, University Hospital Doctor Negrin of Gran Canaria, Las Palmas de Gran Canaria, Spain.
Coralia SosaDepartment of Neurosurgery, University Hospital Doctor Negrin of Gran Canaria, Las Palmas de Gran Canaria, Spain.
Francisco J Balea-FernandezResearch Institute for Applied Microelectronics, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
Jesus MoreraDepartment of Neurosurgery, University Hospital Doctor Negrin of Gran Canaria, Las Palmas de Gran Canaria, Spain.
Bernardino ClavoFundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), Las Palmas de Gran Canaria, Spain.ORCID http://orcid.org/0000-0003-2522-1064
Gustavo M CallicoResearch Institute for Applied Microelectronics, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.ORCID http://orcid.org/0000-0002-3784-5504
Hospital Universitario de Gran Canaria Doctor Negrín · ESUniversidad de Las Palmas de Gran Canaria · ESAutonomous University of San Luis Potosí · MXColorado School of Public Health · US

Funding

Agencia Canaria de Investigación, Innovación y Sociedad de la Información (ACIISI) ProID2017010164
6 · The paper itself

Abstract

Brain surgery is one of the most common and effective treatments for brain tumour. However, neurosurgeons face the challenge of determining the boundaries of the tumour to achieve maximum resection, while avoiding damage to normal tissue that may cause neurological sequelae to patients. Hyperspectral (HS) imaging (HSI) has shown remarkable results as a diagnostic tool for tumour detection in different medical applications. In this work, we demonstrate, with a robust k-fold cross-validation approach, that HSI combined with the proposed processing framework is a promising intraoperative tool for in-vivo identification and delineation of brain tumours, including both primary (high-grade and low-grade) and secondary tumours. Analysis of the in-vivo brain database, consisting of 61 HS images from 34 different patients, achieve a highest median macro F1-Score result of 70.2 ± 7.9% on the test set using both spectral and spatial information. Here, we provide a benchmark based on machine learning for further developments in the field of in-vivo brain tumour detection and delineation using hyperspectral imaging to be used as a real-time decision support tool during neurosurgical workflows.

Identifiers

PMID37964078
PMCPMC10646050
OpenAlexW4388665212

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.